Catheter Precision (VTAK) announced on Wednesday preliminary unaudited record revenues of $1.04M for the quarter ended June 30, 2026, including both the MedTech segment and the Flyte Vision Jet segment. Shares of VTAK gained over 20% during pre-market trading hours
Catheter Precision (VTAK) announced on Wednesday preliminary unaudited record revenues of $1.04M for the quarter ended June 30, 2026, including both the MedTech segment and the Flyte Vision Jet segment.
Shares of VTAK gained over 20% during pre-market trading hours
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.
